Chagas disease

Last updated: September 5, 2022

Summarytoggle arrow icon

Chagas disease (American trypanosomiasis) is an infectious disease caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), which is typically transmitted by triatomine bugs of the Reduviid family. Chagas disease is endemic to Central and South America and most cases that occur in the US are reported in immigrants from endemic regions. Patients present initially with fever, swelling at the site of inoculation of triatomine feces, and generalized lymphadenopathy. These symptoms resolve within a few weeks, and the patient enters an asymptomatic latent phase, which may last for 10–20 years. Eventually, 10–30% of all infected patients enter a chronic phase and develop symptoms of Chagas cardiomyopathy and/or gastrointestinal disease characterized by achalasia and progressive dilation of the colon. The disease is diagnosed by thin and thick peripheral smears in the acute phase and by serological tests in the chronic phase. Chagas disease patients are treated with the antitrypanosomal drugs benznidazole and nifurtimox. Supportive therapy is required for Chagas cardiomyopathy and gastrointestinal disease. Treatment of Chagas disease is most effective when initiated early (in the acute phase).

Epidemiologytoggle arrow icon

Epidemiological data refers to the US, unless otherwise specified.

Etiologytoggle arrow icon

Pathophysiologytoggle arrow icon

Clinical featurestoggle arrow icon

Diagnosticstoggle arrow icon

Chagas disease should be suspected in immigrants from endemic regions.

Treatmenttoggle arrow icon

Antitrypanosomal therapy

Treatment against Chagas disease is most effective when initiated early (in the acute phase).

Chagas disease is caused by the kissing bug and treated with nifurtimox or Benznidazole: “I'm blowing charming kisses from my nifty Benz.”

Supportive therapy

Preventiontoggle arrow icon

  • Instructions for people traveling to or working in endemic regions
    • Use insect repellents and insecticide-treated bed nets.
    • Avoid sleeping in poorly constructed houses with thatched roofs and cracked walls.
  • Public health measures
    • Screening of blood donors
    • Screening of neonates born to infected mothers
    • Vector control methods such as insecticide spraying and reduviid-proof housing
    • Food hygiene

No vaccination against T. cruzi is available and chemoprophylaxis is not recommended!

Referencestoggle arrow icon

  1. Filigheddu MT, Górgolas M, Ramos JM. Enfermedad de Chagas de transmisión oral. Med Clin (Barc). 2017; 148 (3): p.125-131.doi: 10.1016/j.medcli.2016.10.038 . | Open in Read by QxMD
  2. Santana RAG, Guerra MGVB, Sousa DR, et al. Oral Transmission of Trypanosoma cruzi, Brazilian Amazon. Emerg Infect Dis. 2018; 25 (1): p.132-135.doi: 10.3201/eid2501.180646 . | Open in Read by QxMD

Icon of a lock3 free articles remaining

You have 3 free member-only articles left this month. Sign up and get unlimited access.
 Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer